Numerai’s Pediatrix Medical MD Stock Holding History

Numerai’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-22,699	Closed	-$329K	–	563
2025 Q1	$329K	Buy	22,699 +6,424	+39%	+$91.2K	0.06%	364
2024 Q4	$214K	Buy	+16,275	New	+$225K	0.06%	347

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Numerai's MD Position: Q2 2025 in Review

Numerai sold out of Pediatrix Medical (MD) in Q2 2025, closing a stake of 22,699 shares — an estimated $329K sold.

Numerai first reported a position in MD in Q4 2024 and held it in 2 quarters. The position peaked at $329K in Q1 2025. 264 funds tracked by Wall St. Rank hold MD as of Q2 2025.

Numerai reported no remaining Pediatrix Medical position as of Q2 2025 after selling out during the quarter.
Numerai sold 22,699 Pediatrix Medical shares in Q2 2025, an estimated $329K.
Numerai first reported a position in Pediatrix Medical in Q4 2024 and held it in 2 quarters.
Numerai's Pediatrix Medical position peaked at $329K in Q1 2025.
264 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2025.

Based on Numerai's 13F filing for Q2 2025, filed 14 Aug 2025.